Viewing Study NCT07054632


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-01-05 @ 6:10 PM
Study NCT ID: NCT07054632
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-10
First Post: 2025-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations
Sponsor: Innostellar Biotherapeutics Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module